Balanced news tone
News Sentiment
ABBV34 sentiment intelligence
AbbVie Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-7.7% over one week, +9.8% over four weeks, trend inactive, and materially above fair value.
BMO raises Abbvie stock price target to $300 on Skyrizi strength
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
BMO raises Abbvie stock price target to $300 on Skyrizi strength
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 13:02
- Source
- Investing.com
A Look at AbbVie Inc (ABBV) After 3.5% Gain -- GF Value $211.36 vs Price $243.14
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- GuruFocus
The $11 Billion Reason Abbvie Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Barchart.com
AbbVie Inc. (ABBV) Announces Acquisition of Apogee Therapeutics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- GuruFocus
AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 Jun 2026 07:00
- Source
- Investing.com
AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Barchart.com
Earnings call transcript: AbbVie Q1 2026 beats expectations, stock dips
- Tone
- Positive 85/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- Investing.com
Top Dividend Stocks for Income: AbbVie & Enbridge Analysis | 2026 Market - News and Statistics
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 20 Apr 2026 07:00
- Source
- IndexBox
Is AbbVie Stock Underperforming the Dow?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barchart.com
Barclays initiates Abbvie stock with overweight on leverage potential
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 20 Feb 2026 08:00
- Source
- Investing.com
Beyond the Balance Sheet: What SWOT Reveals About AbbVie Inc (AB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Feb 2026 08:00
- Source
- GuruFocus
AbbVie (ABBV) Maintains Quarterly Dividend of $1.73/Share
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 19 Feb 2026 08:00
- Source
- GuruFocus
Earnings call transcript: AbbVie Q4 2025 beats earnings estimates, stock dips
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- Investing.com
AbbVie Reports Third-Quarter 2025 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 31 Oct 2025 07:00
- Source
- PR Newswire
AbbVie Declares Quarterly Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 05 Sep 2025 07:00
- Source
- PR Newswire
Why AbbVie Inc. (ABBV) Is One of the Most Undervalued Pot Stocks to Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Nov 2024 08:00
- Source
- Market source